Taconic Capital Advisors LP

Q4 2024 13F Holdings Report, New Holdings, Stock Holdings

Signature - Title
Alyssa Yavner - Chief Financial Officer
Location
New York, NY
Holdings as of
31 Dec 2024
Value $
$77M
Num holdings
2
Filing time
14 Nov 2025, 13:31:45 UTC
Form type
13F-HR/A-3 - New Holdings
Description
Top holdings included ALE and AMED. Request for Confidential Treatment (14 Feb 2025): Confidential Treatment Expired on 14 Nov 2025.
Previous filing
Q3 2024 - 14 Nov 2024
Next filing
Q1 2025 - 15 May 2025
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

This filing lists securities holdings reported on the form 13F filed on 14 Feb 2025 pursuant to a request for confidential treatment and for which confidential treatment expired on 14 Nov 2025.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Alyssa Yavner Chief Financial Officer New York, New York 14 Nov 2025

Other Included Managers (1):

Num Name Location File Number
1 Taconic Capital Advisors UK LLP London, United Kingdom 028-12491